Relay Therapeutics, Inc. (RLAY) stock
RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.47−0.80 (-4.63%)
Close on Nov 17, 2026Market cap $3.61BP/E –Yield –
Relay Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Relay Therapeutics's price to book ratio was 4.8× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 0.6× to 5.5×, with a median of 1.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.8× | +2.4 |
| 2025 | Dec 31, 2025 | 2.4× | +1.6 |
| 2024 | Dec 31, 2024 | 0.8× | −0.9 |
| 2023 | Dec 29, 2023 | 1.7× | −0.1 |
| 2022 | Dec 30, 2022 | 1.8× | −3.2 |
| 2021 | Dec 31, 2021 | 5.0× | −0.2 |
| 2020 | Dec 31, 2020 | 5.2× | – |
See a number that looks wrong?